QUANTALPHA Foundation and the World Federation of Nuclear Medicine and Biology (WFNMB) cooperate to advance Theranostics worldwide

by admin | Jul 5, 2026 | Q-Press Releases

The strategic partnership will also support the WHO resolution WHA78.13 with the aim to improve access to medical imaging and nuclear medicine February 25, 2026 – Wiesbaden, Germany. The International Centers for Precision Oncology (ICPO) Foundation and the World...

QUANTALPHA and UroTeragLATAM signed a strategic agreement to accelerate Theranostics for urological cancer in Latin America

by admin | Jul 5, 2026 | Q-Press Releases

The partnership strengthens education, innovation, and patient access by combining global expertise with regional leadership in precision oncology. February 27, 2026 – Wiesbaden, Germany and Miami, USA. The International Centers for Precision Oncology (QUANTALPHA)...

QUANTALPHA Foundation Strengthens Scientific Advisory Board (SAB) and Guidance towards Sustainable Patient Access to Theranostics

by admin | Jul 5, 2026 | Q-Press Releases

Prof. Frederik L. Giesel is taking the new position of Co-Chair, and Prof. Akram Al-Ibraheem is joining as the first SAB member from the Middle East. March 5, 2026 – Wiesbaden, Germany. The International Centers for Precision Oncology (QUANTALPHA ) Foundation...